Project Description
Dr. Kumar explored whether supplementation of the diets of prostate cancer patients with the soy isoflavone, genistein, will lead to a decrease in the levels of biomarkers which are indicative of a risk for prostate cancer.
Dr. Kumar explored whether supplementation of the diets of prostate cancer patients with the soy isoflavone, genistein, will lead to a decrease in the levels of biomarkers which are indicative of a risk for prostate cancer.